CD274 and neoplasm: Several recent observations have suggested that tumors with defects in homologous recombination (HR) pathway display genomic instability, high tumor mutational burden, and an increased repertoire of neoantigens, are more immunogenic, leading to adaptive upregulation of PD-L1 by tumor and sensitization to ICI [16].